2',6'-DIHYDROXY-4,4'-DIMETHOXYCHALCONE - Names and Identifiers
Name | 2',6'-DIHYDROXY-4,4'-DIMETHOXYCHALCONE
|
Synonyms | GYMNOGRAMMENE 2',6'-Dihydroxy-4,4'-dimethoxy 2',6'-DIHYDROXY-4,4'-DIMETHOXYCHALCONE DIHYDROXY-4,4'-DIMETHOXYCHALCONE, 2',6'- 1-(2,6-Dihydroxy-4-methoxyphenyl)-3-(4-methoxyphenyl)-2-propene-1-one 2-Propen-1-one, 1-(2,6-dihydroxy-4-methoxyphenyl)-3-(4-methoxyphenyl)-
|
CAS | 20621-49-2
|
2',6'-DIHYDROXY-4,4'-DIMETHOXYCHALCONE - Physico-chemical Properties
Molecular Formula | C17H16O5
|
Molar Mass | 300.31 |
Melting Point | 165°C |
Boling Point | 556°C at 760mmHg |
Solubility | Almost insoluble (0.03g/L) (25°C), |
Storage Condition | 2-8℃ |
2',6'-DIHYDROXY-4,4'-DIMETHOXYCHALCONE - Introduction
2 ',6'-DIHYDROXY-4,4 '-dimethoxychelone is an organic compound with the chemical formula C17H16O5. It has a light yellow crystalline solid.
The compound has the following properties:
1. Melting Point: about 125-129 ° C
2. Solubility: Soluble in common organic solvents such as chloroform, ethanol and dimethyl sulfoxide, insoluble in water.
3. UV absorption: It has a strong absorption peak in the ultraviolet region, and the wavelength is between 280-320 nm.
2 ',6'-DIHYDROXY-4,4 '-dimethoxychelone has certain biological activity, so it has certain application potential in the field of medicine and biological science. Some studies have shown that it has antibacterial, antioxidant, anti-inflammatory and anti-tumor activities.
The method for preparing 2 ',6'-DIHYDROXY-4,4 '-dimethoxychelone is as follows:
C17H16O5 is separated from kaolin by differential resistance liquid chromatography, and then by adding sodium butyrate, bromine to CH benzonitrile and CH3ONa reaction, octyl anisole is obtained, this is subsequently hydrogenated to give the desired 2 ',6'-DIHYDROXY-4,4 '-dimethoxychelone compound.
Regarding safety information, there is currently no toxicity assessment report for this compound. However, as with other chemicals, follow safe practices, wear appropriate personal protective equipment, and avoid contact with skin, eyes, and inhalation of powders or vapours.
Last Update:2024-04-09 20:45:29